Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
India’s pharmaceutical sector faces scrutiny in the latest USTR Special 301 Report over intellectual property rights enforcement, particularly in formulations. Industry leaders stress compliance with WTO norms and advocate for policy measures to protect and promote the formulations segment, highlighting the sector’s v…
Share This Article
Ready-to-post copy includes the article link.
Indian Pharma Industry Calls for Enhanced Support Amid USTR Special 301 Report Concerns India’s pharmaceutical sector faces scrutiny in the latest USTR Special 301 Report over intellectual property rights enforcement, particularly in formulations. Industry leaders stress compliance with WTO norms and advoc... Read the full IIPLA article: https://iipla.org/news/indian-pharma-industry-calls-for-enhanced-support-amid-ustr-special-301-report-concerns